Skip to main content
Log in

Microparticles from human the lower airway show inhibitory activity against respiratory syncytial virus

  • Brief Report
  • Published:
Archives of Virology Aims and scope Submit manuscript

Abstract

Airway microparticles (MPs) have been shown previously to inhibit influenza virus by trapping virions on their surface through their surface viral receptor. It was hypothesized that airway MPs may carry most of the epithelial cell surface molecules, including receptors for respiratory viruses, and may be able to inhibit various respiratory viruses. We show here that MPs from human bronchoalveolar lavage (BAL) can inhibit respiratory syncytial virus (RSV). Those MPs stained positive for the RSV receptor, CX3CR1. Furthermore, incubating the MPs with a monoclonal antibody against CX3CR1 reduced the anti-RSV activity. These data indicate that MPs can contribute to respiratory innate antiviral defense.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Gyorgy B, Szabo TG, Pasztoi M, Pal Z, Misjak P, Aradi B, Laszlo V, Pallinger E, Pap E, Kittel A, Nagy G, Falus A, Buzas EI (2011) Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. https://doi.org/10.1007/s00018-011-0689-3

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mause SF, Weber C (2010) Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res. https://doi.org/10.1161/CIRCRESAHA.110.226456

    Article  PubMed  Google Scholar 

  3. Suptawiwat O, Ruangrung K, Boonarkart C, Puthavathana P, Maneechotesuwan K, Charngkaew K, Chomanee N, Auewarakul P (2017) Microparticle and anti-influenza activity in human respiratory secretion. PLoS ONE. https://doi.org/10.1371/journal.pone.0183717

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ascough S, Paterson S, Chiu C (2018) Induction and subversion of human protective immunity: contrasting influenza and respiratory syncytial virus. Front Immunol 9:323

    Article  Google Scholar 

  5. Johnson SM, McNally BA, Ioannidis I, Flano E, Teng MN, Oomens AG, Walsh EE, Peeples ME (2015) Respiratory syncytial virus uses CX3CR1 as a receptor on primary human airway epithelial cultures. PLoS Pathog. https://doi.org/10.1371/journal.ppat.1005318

    Article  PubMed  PubMed Central  Google Scholar 

  6. Mastrangelo P, Hegele RG (2012) The RSV fusion receptor: not what everyone expected it to be. Microbes Infect. https://doi.org/10.1016/j.micinf.2012.07.015

    Article  PubMed  Google Scholar 

  7. Kota S, Sabbah A, Chang TH, Harnack R, Xiang Y, Meng X, Bose S (2008) Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus. J Biol Chem 283:22417–22429

    Article  CAS  Google Scholar 

  8. Sano H, Nagai K, Tsutsumi H, Kuroki Y (2003) Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection. Eur J Immunol 33:2894–2902

    Article  CAS  Google Scholar 

  9. Watson A, Kronqvist N, Spalluto CM, Griffiths M, Staples KJ, Wilkinson T, Holmskov U, Sorensen GL, Rising A, Johansson J, Madsen J, Clark H (2017) Novel expression of a functional trimeric fragment of human SP-A with efficacy in neutralisation of RSV. Immunobiology. https://doi.org/10.1016/j.imbio.2016.10.015

    Article  PubMed  PubMed Central  Google Scholar 

  10. Gyorgy B, Szabo TG, Turiak L, Wright M, Herczeg P, Ledeczi Z, Kittel A, Polgar A, Toth K, Derfalvi B, Zelenak G, Borocz I, Carr B, Nagy G, Vekey K, Gay S, Falus A, Buzas EI (2012) Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases. PLoS ONE. https://doi.org/10.1371/journal.pone.0049726

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study was supported by a research grant from the National Research Council of Thailand and partly supported by the Faculty of Medicine Siriraj Hospital, Mahidol University. We would like to thank Disayabutr S. and Ahussabhumi J. for clinical assistance in BAL sample collection.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Prasert Auewarakul.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Additional information

Handling Editor: Bert K. Rima

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Boonarkart, C., Suptawiwat, O., Ruangrung, K. et al. Microparticles from human the lower airway show inhibitory activity against respiratory syncytial virus. Arch Virol 166, 2579–2584 (2021). https://doi.org/10.1007/s00705-021-05144-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00705-021-05144-5

Navigation